EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node



Axillary recurrence rate in breast cancer patients with negative sentinel lymph node



Croatian Medical Journal 46(3): 377-381



Aim To assess the axillary recurrence rate inoperable breast cancer patients with clinically negative axil la after negative sentinel lymph node in whom axillary lymph node dissection had not been performed.Methods Fifty consecutive female operable breast cancer patients with negative sentinel lymph node biopsy in whom axillary lymph node dissection had not been performed were included in the study and prospectively followed, with median follow-up time of 32 months (range 10-50 months).

(PDF emailed within 1 workday: $29.90)

Accession: 011794922

Download citation: RISBibTeXText

PMID: 15861515



Related references

Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. American Journal of Surgery 196(4): 562-565, 2008

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Annals of Surgery 241(1): 152-158, 2004

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. European Surgery 37(3): 178-180, 2005

Axillary Recurrence Rate in Breast Cancer Patients With Negative Sentinel Lymph Node (SLN) or SLN Micrometastases: Prospective Analysis of 150 Patients After SLN Biopsy. Yearbook of Surgery 2006: 325-326, 2006

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases. Breast Journal 17(4): 337-342, 2011

Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. European Journal of Surgical Oncology 31(7): 715-720, 2005

Axillary recurrence in sentinel lymph node-negative breast cancer patients. Annals of Oncology 19(11): 1842-1846, 2008

O-69 Axillary recurrence in breast cancer patients after a negative sentinel lymph node biopsy. European Journal of Cancer Supplements 5(3): 21-22, 2007

Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer. Bmc Cancer 15(): 382-382, 2016

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. Bmc Cancer 16(1): 808-808, 2016

Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Journal of Surgical Oncology 93(2): 129-132, 2006

Axillary recurrence of breast cancer following negative sentinel lymph node biopsy and axillary clearance. European Journal of Surgical Oncology 26(6): 629-629, 2000

Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients. European Journal of Surgical Oncology 29(3): 221-223, 2003

Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital. Breast Cancer 23(2): 318-322, 2014

Axillary recurrences after sentinel lymph node biopsy: A multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients. Breast Diseases: A Year Book Quarterly 24(2): 172-173, 2013